Lunai Bioworks Inc.
For the period ended Jun 30, 2025. Filed Sep 29, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Sep 29, 2025
LNAI$0.16-30.2%Stored close · as of Oct 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
Lunai Bioworks Inc. AND SUBSIDIARIES
Index to Consolidated Financial Statements
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID:3627) | F-2 |
|---|---|
| Consolidated Balance Sheets at June 30, 2025 and 2024 | F-4 |
| Consolidated Statements of Operations for the Years Ended June 30, 2025 and 2024 | F-5 |
| Consolidated Statements of Comprehensive Loss for the Years Ended June 30, 2025 and 2024 | F-6 |
| Consolidated Statement of Stockholders’ Equity (Deficit) for the Years Ended June 30, 2025 and 2024 | F-7 |
| Consolidated Statements of Cash Flows for the Years Ended June 30, 2025 and 2024 | F-8 |
| Notes to the Consolidated Financial Statements | F-9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.